127 related articles for article (PubMed ID: 7494899)
21. Final report of the safety assessment of Alcohol Denat., including SD Alcohol 3-A, SD Alcohol 30, SD Alcohol 39, SD Alcohol 39-B, SD Alcohol 39-C, SD Alcohol 40, SD Alcohol 40-B, and SD Alcohol 40-C, and the denaturants, Quassin, Brucine Sulfate/Brucine, and Denatonium Benzoate.
Cosmetic Ingredient Review Expert Panel
Int J Toxicol; 2008; 27 Suppl 1():1-43. PubMed ID: 18569160
[TBL] [Abstract][Full Text] [Related]
22. Amended final report on the safety assessment of polyacrylamide and acrylamide residues in cosmetics.
Int J Toxicol; 2005; 24 Suppl 2():21-50. PubMed ID: 16154914
[TBL] [Abstract][Full Text] [Related]
23. NTP center for the evaluation of risks to human reproduction reports on phthalates: addressing the data gaps.
McKee RH; Butala JH; David RM; Gans G
Reprod Toxicol; 2004; 18(1):1-22. PubMed ID: 15013060
[TBL] [Abstract][Full Text] [Related]
24. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
Kirman CR; Sweeney LM; Corley R; Gargas ML
Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
[TBL] [Abstract][Full Text] [Related]
25. Literature review on the genotoxicity, reproductive toxicity, and carcinogenicity of ethyl methanesulfonate.
Gocke E; Bürgin H; Müller L; Pfister T
Toxicol Lett; 2009 Nov; 190(3):254-65. PubMed ID: 19857796
[TBL] [Abstract][Full Text] [Related]
26. Calculation of benchmark doses for reproductive and developmental toxicity observed after exposure to isopropanol.
Allen B; Gentry R; Shipp A; Van Landingham C
Regul Toxicol Pharmacol; 1998 Aug; 28(1):38-44. PubMed ID: 9784431
[TBL] [Abstract][Full Text] [Related]
27. Bootstrap estimation of benchmark doses and confidence limits with clustered quantal data.
Zhu Y; Wang T; Jelsovsky JZ
Risk Anal; 2007 Apr; 27(2):447-65. PubMed ID: 17511711
[TBL] [Abstract][Full Text] [Related]
28. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
Bokkers BG; Slob W
Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
[TBL] [Abstract][Full Text] [Related]
29. Paradigm lost, paradigm found: the re-emergence of hormesis as a fundamental dose response model in the toxicological sciences.
Calabrese EJ
Environ Pollut; 2005 Dec; 138(3):379-411. PubMed ID: 16098930
[TBL] [Abstract][Full Text] [Related]
30. Final amended report on the safety assessment of Methylparaben, Ethylparaben, Propylparaben, Isopropylparaben, Butylparaben, Isobutylparaben, and Benzylparaben as used in cosmetic products.
Int J Toxicol; 2008; 27 Suppl 4():1-82. PubMed ID: 19101832
[TBL] [Abstract][Full Text] [Related]
31. The no-observed-adverse-effect-level in drug safety evaluations: use, issues, and definition(s).
Dorato MA; Engelhardt JA
Regul Toxicol Pharmacol; 2005 Aug; 42(3):265-74. PubMed ID: 15979222
[TBL] [Abstract][Full Text] [Related]
32. Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects.
Shipp A; Lawrence G; Gentry R; McDonald T; Bartow H; Bounds J; Macdonald N; Clewell H; Allen B; Van Landingham C
Crit Rev Toxicol; 2006; 36(6-7):481-608. PubMed ID: 16973444
[TBL] [Abstract][Full Text] [Related]
33. An evaluation of reported no-effect chrysotile asbestos exposures for lung cancer and mesothelioma.
Pierce JS; McKinley MA; Paustenbach DJ; Finley BL
Crit Rev Toxicol; 2008; 38(3):191-214. PubMed ID: 18324516
[TBL] [Abstract][Full Text] [Related]
34. Precision of benchmark dose estimates for continuous (nonquantal) measurements of toxic effects.
Gaylor DW; Chen JJ
Regul Toxicol Pharmacol; 1996 Aug; 24(1 Pt 1):19-23. PubMed ID: 8921542
[TBL] [Abstract][Full Text] [Related]
35. New approach to risk assessment of central neurotoxicity induced by 1-bromopropane using animal models.
Fueta Y; Ishidao T; Ueno S; Yoshida Y; Kunugita N; Hori H
Neurotoxicology; 2007 Mar; 28(2):270-3. PubMed ID: 16782201
[TBL] [Abstract][Full Text] [Related]
36. [The concept of risk and its estimation].
Zocchetti C; Della Foglia M; Colombi A
Med Lav; 1996; 87(4):330-47. PubMed ID: 9102559
[TBL] [Abstract][Full Text] [Related]
37. Chemical mixtures: current risk assessment methodologies and future directions.
Seed J; Brown RP; Olin SS; Foran JA
Regul Toxicol Pharmacol; 1995 Aug; 22(1):76-94. PubMed ID: 7494906
[TBL] [Abstract][Full Text] [Related]
38. Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: approaches to dose selection.
Rhomberg LR; Baetcke K; Blancato J; Bus J; Cohen S; Conolly R; Dixit R; Doe J; Ekelman K; Fenner-Crisp P; Harvey P; Hattis D; Jacobs A; Jacobson-Kram D; Lewandowski T; Liteplo R; Pelkonen O; Rice J; Somers D; Turturro A; West W; Olin S
Crit Rev Toxicol; 2007; 37(9):729-837. PubMed ID: 17957539
[TBL] [Abstract][Full Text] [Related]
39. Safety evaluation and risk assessment of the herbicide Roundup and its active ingredient, glyphosate, for humans.
Williams GM; Kroes R; Munro IC
Regul Toxicol Pharmacol; 2000 Apr; 31(2 Pt 1):117-65. PubMed ID: 10854122
[TBL] [Abstract][Full Text] [Related]
40. Final report on the safety assessment of 6-Amino-m-Cresol, 6-Amino-o-Cresol, 4-Amino-m-Cresol, 5-Amino-4-Chloro-o-Cresol, 5-Amino-6-Chloro-o-Cresol, and 4-Chloro-2-Aminophenol.
Int J Toxicol; 2004; 23 Suppl 2():1-22. PubMed ID: 15513822
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
